Validation of a questionnaire for assessing urinary treatment constraints
Official title: Validation of the Short Form of the "Lower Urinary Tract Symptoms Treatment Constraints Assessment" Questionnaire
Run by Centre Hospitalier de Saint-Denis · NCT06853366 · Data updated 2026-11-12
This study is trying to see if a new questionnaire can help understand how urinary treatments affect the lives of adults with neurological conditions.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 242 (estimated) |
| Sponsor | Centre Hospitalier de Saint-Denis Academic / other |
| Locations | 2 sites (Paris, paris and 1 other locations) |
| Status | Recruiting |
| Started | February 20, 2025 |
| Main results expected | February 20, 2026 |
| Study ends | December 1, 2026 |
| Registry record updated | February 28, 2025 |
| Trial ID | NCT06853366 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adult patients aged 18 and older with neurological conditions affecting bladder function who have been on urinary treatment for more than three months.
✕Probably not a fit
Patients who are minors, have stopped urinary treatment, or have significant cognitive impairments may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to validate a short form of the 'Lower Urinary Tract Symptoms Treatment Constraints Assessment' questionnaire, which focuses on patient-reported outcomes related to urologic disorders. The study will assess various domains such as patient satisfaction, quality of life, and the constraints or side effects associated with urinary treatments. Adult patients with neurological conditions affecting bladder function will be recruited, and their experiences will be quantified to enhance the understanding of treatment impacts. The study emphasizes the importance of including patient perspectives in evaluating treatment effectiveness.
Why it matters
Potential benefit: If successful, this study could lead to improved assessment tools that better capture the patient experience and treatment constraints, ultimately enhancing patient care.
How similar studies have gone: While there are few studies focusing on similar multidimensional questionnaires in neurology, the approach of validating patient-reported outcomes is increasingly recognized, suggesting potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients (age ≥ 18 years) * Patients with central or peripheral neurological pathology, followed and managed for vesico-sphincter disorders * Patients receiving urinary treatment for more than 3 months * No therapeutic modification between D0 and D14 of the questionnaire * French-speaking patients (able to read, write and understand French) Exclusion Criteria: * Minor patients (age ≤ 17 years) * Patients who have stopped urinary treatment * Patients with major cognitive impairment * Patients who speak little or no French * Patients who refused to participate in research, or who objected to the use of their data for research purposes
Where it's running
-
La pitié salpêtrière
Paris, paris, France Recruiting -
Casanova Hospital
Saint-Denis, Seine saint denis, France Not yet recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Noninvasive spinal cord stimulation for recovery after spinal cord injury
This study is testing a new non-invasive treatment to see if it can help improve bladder, bowel, sexual, and heart functions in people who have had a spinal cord injury for a few months.
-
Using stem cells to treat various chronic and acute health conditions
This study is testing if stem cell therapy can help people with different long-term and short-term health issues, like autoimmune diseases and heart problems, feel better and improve their quality of life.
-
Recognizing dapagliflozin overdose in ICU patients admitted for metformin poisoning.
This project will see if clinical signs and routine lab tests can help doctors tell whether adults in the ICU for metformin poisoning also took too much dapagliflozin.
-
Comparing how the uterus expands during hysterosonography in women monitored for fertility
This test sees if uterine volume changes measured during hysterosonography differ between women receiving IVF/ICSI care for infertility and women who are apparently fertile.
-
Single antibiotic versus two antibiotics for Pseudomonas bone infection
This study will test whether one antibiotic works as well as two for adults with bone infections caused by Pseudomonas aeruginosa.
-
Antibiotic approaches for Stenotrophomonas maltophilia pneumonia in ICU patients
This study tests whether using one antibiotic versus two, and whether treating for 7 days versus 14 days, helps adults on ventilators in the ICU with Stenotrophomonas maltophilia pneumonia survive and avoid recurrence.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.